19-41193319-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030622.8(CYP2S1):c.55C>A(p.Leu19Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000817 in 1,541,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030622.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP2S1 | NM_030622.8 | c.55C>A | p.Leu19Met | missense_variant | 1/9 | ENST00000310054.9 | |
CYP2S1 | XM_047438711.1 | c.55C>A | p.Leu19Met | missense_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP2S1 | ENST00000310054.9 | c.55C>A | p.Leu19Met | missense_variant | 1/9 | 1 | NM_030622.8 | P1 | |
CYP2S1 | ENST00000600561.1 | c.55C>A | p.Leu19Met | missense_variant | 1/4 | 2 | |||
CYP2S1 | ENST00000597754.1 | c.55C>A | p.Leu19Met | missense_variant | 1/4 | 5 | |||
CYP2S1 | ENST00000593545.5 | c.55C>A | p.Leu19Met | missense_variant, NMD_transcript_variant | 1/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000811 AC: 11AN: 135620Hom.: 0 AF XY: 0.0000816 AC XY: 6AN XY: 73502
GnomAD4 exome AF: 0.0000698 AC: 97AN: 1389454Hom.: 0 Cov.: 31 AF XY: 0.0000613 AC XY: 42AN XY: 685146
GnomAD4 genome AF: 0.000190 AC: 29AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.55C>A (p.L19M) alteration is located in exon 1 (coding exon 1) of the CYP2S1 gene. This alteration results from a C to A substitution at nucleotide position 55, causing the leucine (L) at amino acid position 19 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at